Legacy Pharmaceutical Packaging Acquires Multiple Blister Production Lines from McKesson RxPak

St. Louis, MO – Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, compliance and secondary packaging services, has purchased three high speed blistering and cartoning lines with serialization and aggregation capabilities from McKesson RxPak’s production facility in Memphis. The infrastructure acquisition nearly doubles Legacy’s total blister production capacity, which now stands at half a billion packs per year. In a separate equipment investment, this summer Legacy also will add an additional new high-speed bottling line, bringing the contract packager’s bottling capacity to some 600 million unit

Featured Posts
Recent Posts
Search By Tags

© 2020 by Legacy Pharma Solutions